Chronic multifocal Langerhans cell histiocytosis

From WikiMD's WELLNESSPEDIA

File:Hans-Schuller-Christian.jpg
Hans-Schuller-Christian

Rare disease involving the proliferation of Langerhans cells

Chronic multifocal Langerhans cell histiocytosis





Specialty Hematology, Oncology
Symptoms Bone pain, skin rash, fever, weight loss
Complications Diabetes insipidus, lung disease, liver disease
Usual onset Childhood
Duration Chronic


Causes Unknown


Diagnosis Biopsy, Imaging studies
Differential diagnosis Osteomyelitis, Ewing sarcoma, Lymphoma


Treatment Chemotherapy, Radiation therapy, Surgery


Prognosis Variable
Frequency Rare


Chronic multifocal Langerhans cell histiocytosis (CMLCH) is a rare disease characterized by the proliferation of Langerhans cells, a type of dendritic cell that normally helps regulate the immune system. This condition is part of a group of disorders known as Langerhans cell histiocytosis (LCH).

Presentation[edit]

CMLCH typically presents in childhood and can affect multiple organs. Common symptoms include bone pain, skin rash, fever, and weight loss. The disease can lead to complications such as diabetes insipidus, lung disease, and liver disease.

Pathophysiology[edit]

The exact cause of CMLCH is unknown. It involves the abnormal accumulation and proliferation of Langerhans cells in various tissues, leading to the formation of granulomas and tissue damage.

Diagnosis[edit]

Diagnosis of CMLCH is based on clinical presentation, biopsy of affected tissues, and imaging studies such as X-ray, CT scan, and MRI. The biopsy typically shows the presence of Langerhans cells, which can be identified by their characteristic markers.

Differential Diagnosis[edit]

The differential diagnosis for CMLCH includes:

Treatment[edit]

Treatment options for CMLCH include:

  • Chemotherapy: Often used to reduce the number of Langerhans cells.
  • Radiation therapy: Used in cases where the disease is localized.
  • Surgery: May be necessary to remove isolated lesions.

Prognosis[edit]

The prognosis for CMLCH is variable and depends on the extent of organ involvement and response to treatment. Some patients may experience a chronic course with periods of remission and relapse.

See also[edit]

References[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Chronic_multifocal_Langerhans_cell_histiocytosis&oldid=5831570"